Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

226 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study.
Sahebjam S, Forsyth PA, Tran ND, Arrington JA, Macaulay R, Etame AB, Walko CM, Boyle T, Peguero EN, Jaglal M, Mokhtari S, Enderling H, Raghunand N, Gatewood T, Long W, Dzierzeski JL, Evernden B, Robinson T, Wicklund MC, Kim S, Thompson ZJ, Chen DT, Chinnaiyan P, Yu HM. Sahebjam S, et al. Among authors: mokhtari s. Neuro Oncol. 2021 Apr 12;23(4):677-686. doi: 10.1093/neuonc/noaa260. Neuro Oncol. 2021. PMID: 33173935 Free PMC article. Clinical Trial.
Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastases.
Lowe SR, Wang CP, Brisco A, Whiting J, Arrington J, Ahmed K, Yu M, Robinson T, Oliver D, Etame A, Tran N, Beer Furlan A, Sahebjam S, Mokhtari S, Piña Y, Macaulay R, Forsyth P, Vogelbaum MA, Liu JKC. Lowe SR, et al. Among authors: mokhtari s. Neuro Oncol. 2022 Aug 1;24(8):1307-1317. doi: 10.1093/neuonc/noac023. Neuro Oncol. 2022. PMID: 35092434 Free PMC article.
Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy.
Figura NB, Rizk VT, Mohammadi H, Evernden B, Mokhtari S, Yu HM, Robinson TJ, Etame AB, Tran ND, Liu J, Washington I, Diaz R, Czerniecki BJ, Soliman H, Han HS, Sahebjam S, Forsyth PA, Ahmed KA. Figura NB, et al. Among authors: mokhtari s. Breast Cancer Res Treat. 2019 Jun;175(3):781-788. doi: 10.1007/s10549-019-05170-7. Epub 2019 Mar 11. Breast Cancer Res Treat. 2019. PMID: 30859348
Revisiting the Concept of Recurrence of Primary Central Nervous System Lymphomas After Complete Response to Methotrexate-Based Therapy: Periventricular Reseeding as the Predominant Mechanism of Recurrence.
Kutuk T, Grass GD, Oliver D, Mokhtari S, Sahebjam S, Kim S, Penagaricano J, Yu HM, Tran N, Etame A, Peterson JL, Forsyth P, Robinson T. Kutuk T, et al. Among authors: mokhtari s. Adv Radiat Oncol. 2022 Mar 9;7(4):100940. doi: 10.1016/j.adro.2022.100940. eCollection 2022 Jul-Aug. Adv Radiat Oncol. 2022. PMID: 35814853 Free PMC article.
Mitochondrial DNA sequence variation and risk of meningioma.
Samanic CM, Teer JK, Thompson ZJ, Creed JH, Mokhtari S, Fridley BL, Nabors LB, Williams SL, Egan KM. Samanic CM, et al. Among authors: mokhtari s. J Neurooncol. 2021 Dec;155(3):319-324. doi: 10.1007/s11060-021-03878-5. Epub 2021 Oct 20. J Neurooncol. 2021. PMID: 34669147
226 results